Prognostic utility of a personalized ctDNA minimal residual disease test in patients undergoing curative resection of HPV-negative head and neck squamous cell carcinoma.

Authors: Natalya Karasik, Jacob Miller, Chandana Reddy, Shauna Campbell, Kyunghee Burkitt, Tamara A. Sussman, Eric Lamarre, Brandon Prendes, Jamie Ku, Natalie L. Silver, Joseph Scharpf, Jessica Lyn Geiger, Danielle Bottalico, Timothy An-thy Chan, Shlomo A. Koyfman, Neil McIver Woody

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e18113

Source: Full article

---

Abstract

e18113